Notably, it could be interesting to examine the effects of the inhibitors of acid sphingomyelinase on SkM, since these inhibitors are promising therapeutic drugs against COVID-19 [245,246] and, likely, long COVID-19. Here, SMPD1 is linked to COVID-19.